Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significant. [electronic resource]
Producer: 20030501Description: 37-40 p. digitalISSN:- 0167-8140
- Adult
- Aged
- Aged, 80 and over
- Anemia -- chemically induced
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- blood
- Combined Modality Therapy
- Female
- Hemoglobins -- analysis
- Humans
- Lung Neoplasms -- blood
- Male
- Middle Aged
- Paclitaxel -- administration & dosage
- Prognosis
- Radiotherapy -- adverse effects
- Retrospective Studies
- Survival Rate
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.